The world had been anticipating another influenza pandemic since the last one in 1968. The
pandemic influenza A H1N1 2009 virus (A/2009/H1N1) finally arrived, causing the first …

Mass gatherings are characterized by the concentration of people temporally and spatially,
and may lead to the emergence of infectious diseases due to enhanced transmission …

The value of next-generation sequencing (NGS)-based applications for testing purposes in
human medicine is widely recognized. Although NGS-based metagenomic screening may …

Around 2008 or 2009, an influenza A virus that had been circulating undetected in swine
entered human population. Unlike most swine influenza infections of humans, this virus …

The 2009 influenza pandemic provided an opportunity to observe dynamic changes of the
hemagglutinin (HA) and neuraminidase (NA) of pH1N1 strains that spread in two …

This study focuses on design, synthesis and in vitro evaluation of inhibitory potency of two
series of sialylmimetic that target an exosite (“150-cavity”) adjacent to the active site of …

Since the neuraminidase (NA) enzyme of the influenza A virus plays a key role in the
process of release of new viral particles from a host cell, it is often a target for new drug …

Emerging infectious diseases (EIDs) pose international security threats because of their
potential to inflict harm upon humans, crops, livestock, health infrastructure, and economies …

In 2009, a novel H1N1 influenza A virus emerged and spread worldwide, initiating a
pandemic. Various isolates obtained from disparate parts of the world were shown to be …

Since the emergence of the pandemic H1N1pdm09 virus in Mexico and California, biannual
increases in the number of cases have been detected in Mexico. As observed in previous …